Role of Insulin Resistance in MAFLD
Open accessThe DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Abstract
Many studies have reported that metabolic dysfunction is closely involved in the complex mechanism underlying the development of non-alcoholic fatty liver disease (NAFLD), which has prompted a movement to consider renaming NAFLD as metabolic dysfunction-associated fatty liver disease (MAFLD). Metabolic dysfunction in this context encompasses obesity, type 2 diabetes mellitus, hypertension, dyslipidemia, and metabolic syndrome, with insulin resistance as the common underlying pathophysiology. Imbalance between energy intake and expenditure results in insulin resistance in various tissues and alteration of the gut microbiota, resulting in fat accumulation in the liver. The role of genetics has also been revealed in hepatic fat accumulation and fibrosis. In the process of fat accumulation in the liver, intracellular damage as well as hepatic insulin resistance further potentiates inflammation, fibrosis, and carcinogenesis. Increased lipogenic substrate supply from other tissues, hepatic zonation of Irs1, and other factors, including ER stress, play crucial roles in increased hepatic de novo lipogenesis in MAFLD with hepatic insulin resistance. Herein, we provide an overview of the factors contributing to and the role of systemic and local insulin resistance in the development and progression of MAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
The cited source says what the claim attributes to it.
In the citing paper
“ChREBP, which is activated by carbohydrate uptake [9,34,78,83].”
The cited source says what the claim attributes to it.
In the citing paper
“Among the core insulin signaling mediators—including INSR, IRS1, IRS2, AKT1, and AKT2—IRS1 shows marked zonal expression, with approximately 2-fold higher levels in PV compared to PP regions [9,20].”
In the citing paper
“Many studies have shown that insulin- resistant conditions are accompanied by a substantial increase in MTP and apolipoprotein C3 (ApoCIII) expression and the production of hepatic VLDL-ApoB and VLDL-TG [2, 9,108,111].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MORA, A., LIPINA, C., TRONCHE, F., SUTHERLAND, C., & ALESSI, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20041782 · Cited by 92
RetractedSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 2×
“, hepatocyte ballooning), with or without fibrosis [2].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · cited 1×
“The global prevalence of NAFLD is estimated at 24%; the highest rates are reported from South America and the Middle East, followed by Asia, the USA, and Europe [3].”
BackgroundSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Cited by
Items 401–500 of 506
Prediabetes is a window of opportunity for preventive interventions. Part 1
Adasheva, T. V., Евгеньевна, Г. Е., Игоревна, Ф. Е., & Георгиевна, Л. Е. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-407
Ajackson, M., Monteiro, E. B., Martins, F. F., Júnior, J. X. D. N., Neto, E. S. C., do Nascimento, M. D. S. M. A., Camillo, C. D. S., Vieira, J. R. C., Lisboa, P. C., Tavares, D. A. G., et al. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112849
Diabetes duration modifies the association between AIP and MAFLD in type 2 diabetes
Ma, J., Hu, X., Liang, X., & Jin, K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1952511
林, 子. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.163891
Li, M., Yao, Y., Li, T., Cai, T., Zhao, F., Fang, Y., Zheng, Y., Fei, C., Yang, C., Sun, W., et al. (2026) · Nutrients · doi:10.3390/nu18162723
BindingDB Entry 50022803: Glucagon-like peptide-1 analogs: Miracle drugs are blooming?
BindingDB (2026) · UC San Diego · doi:10.7270/q2028xcf
Guo, X., Zhou, Q., Jin, J., Lan, F., Wen, C., Li, J., Yang, N., & Sun, C. (2024) · Figshare · doi:10.6084/m9.figshare.26607088
Guo, X., Zhou, Q., Jin, J., Lan, F., Wen, C., Li, J., Yang, N., & Sun, C. (2024) · Figshare · doi:10.6084/m9.figshare.26607091
Guo, X., Zhou, Q., Jin, J., Lan, F., Wen, C., Li, J., Yang, N., & Sun, C. (2024) · Figshare · doi:10.6084/m9.figshare.26607094
Andrade, L. J. D. O., de Oliveira, G. C. M., & de Oliveira, L. M. (2024) · Research Square · doi:10.21203/rs.3.rs-4739938/v1
Wang, H., Li, H., Liu, Y., Wang, X., He, C., Huang, J., Zhang, Y., Yang, Y., & Ge, N. N. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000866
Liu, J.-R., Zhao, L., Niu, Q., Cai, J.-Z., & Liu, H.-Y. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.121285
Робертовна, М. А., Laevskaya, M. Y., Николаевич, С. Ю., & Babenko, A. Y. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-532
Ding, L., Ren, S., Zang, C., Zheng, L., Jiang, L., Guo, H., Yang, W., Guan, H., & Liu, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-42966-2
Awan, S. A., Wibawa, I. D. N., Jawi, I. M., Pinatih, G. N. I., & Mahendra, A. N. (2023) · Bali Medical Journal · doi:10.15562/bmj.v12i2.4483
Хавкин, А. И., Газаль, А., Михайлович, Н. К., Vasileva, K. A., Shrainer, E., Гурова, М. М., & Новикова, В. П. (2026) · Children s medicine of the North-West · doi:10.56871/cmn-w.2026.48.70.009
郑, 莹. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123641
Gaber, H. F. B., Moawed, F. S., Mahfouz, M. K., Ahmed, E. S. A., & Abo-Zaid, O. A. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71801
Wang, F., Mi, J., Bai, X., Ruan, G., Zhang, Y., & Yu, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1751879/v1
Ma, Y., Xie, M., Li, Y., Li, Q., & Liang, M. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1833372
Xie, J., Zhou, R., Yang, Y., Du, X., Wang, J., Kong, L., Wu, L., Wu, Y., Meng, Y., & Gao, R. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5245700
Lv, Z., Ren, Y., Li, Y., Niu, F., Li, Z., Li, M., Li, X., Li, Q., Huang, D., Yu, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26629016
He, J., Zhang, C., Luo, H., Sun, M., Hu, R., Wang, X., Yang, Y., Xiao, S., Chen, Z., & Yin, X. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1793972
El-Nablaway, M., Adel, M., Fahmy, E. K., Abouhish, H., Dawood, A. F., & Eldesoqui, M. B. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-025-10681-3
Wang, Y., Wan, C., Mu, L., Aijun, Z., Li, Y., LIU, Y. F., Bao, Y., & Bao, F. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1804773
Alshehri, S. A., Osman, M. A., Alnafisah, G., Asiri, S., Arzoo, S., & Al‐Harbi, L. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219453
Fermented Milk as an Alternative Therapy for Obesity
Safitri, U., Rustanti, N., Pramono, A., & Suparmi, S. (2026) · International Journal of Food Science · doi:10.1155/ijfo/5584818
Decoding thyroid: liver cross talk in type 2 diabetes mellitus—an MASLD perspective
Subramani, S., Gayathri, S., & Lakshmanan, K. (2026) · Diabetology International · doi:10.1007/s13340-026-00916-3
Associations between Abnormal Iron Metabolism and Elevated Alanine Aminotransferase in AdultsPreprint
Su, X., Zhang, D., Chen, Z., Han, X., Xia, P., Yin, M., & Zhu, H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4167832
Sakhr, H. M., Hassan, M. H., Taha, A. M., & Bakri, A. H. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2025.00731
LncRNA-Snhg3 Aggravates Hepatic Steatosis by Regulating PPARγ via SND1/H3K27me3Preprint
Xie, X., Gao, M., Zhao, W., Li, C., Zhang, W., Yang, J., Zhang, Y., Chen, E., Guo, Y., Guo, Z., et al. (2024) · eLife · doi:10.7554/elife.96988.1
Nie, J., Zhou, J., Yuanjia, H., Zhang, C., Yu, P., & Lei, X. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s590383
Wang, B., Tang, Y., Li, N., Dai, X., Wu, J., Xue, B., Chen, Y., Zhang, J., Kong, L., Li, C., et al. (2026) · Advanced Science · doi:10.1002/advs.77875
The role of tryptophan hydroxylase‐1 in metabolic dysfunction‐associated steatotic liver disease
Jia, S. D., Ye, X., Wang, Z. M., & Wu, J. (2026) · Pediatric Investigation · doi:10.1002/ped4.70078
dos Santos, E. E. P., de Araújo, R. C., Guijo, J. A., Fonseca, G. D., Balagopal, B., do Prado, W. L., & Botero, J. P. (2026) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003315
Research progress on animal models of metabolic dysfunction-associated fatty liver disease
Lin-Yun, Z. H. A. O., Zhang, X., Zi-Meng, X. I., ZHANG, Q., Chun-Li, M. A., & Bao, Y. (2026) · Shengming kexue · doi:10.3724/cbls.2026017
GATA binding protein 4: Emerging role in liver development and diseases
Wang, H., Zhang, J. C., Li, Y., Chen, S. T., Aishan, M., Ke, Y., Li, Y., & Chen, Y. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12275-y
Hepatogenomics of MAFLD in Asian Population: Genetic Polymorphisms and Pathway-Based Insights
Justyn, M., Sutanto, C., Barliana, M. I., Heryaman, H., Meiliana, A., & Puspitasari, I. M. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s603042
Biya, T., Sanusi, H. D., & Aman, A. M. (2025) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2025.4.10
Castelli, S., Aiello, G., Muthanna, F. M. S., Lammi, C., Tripodi, G., Aiello, V., Lombardo, M., & Baldelli, S. (2026) · Metabolites · doi:10.3390/metabo16110855
Tao, J., Zhong, Y., Li, H., Wang, W., & Tan, J. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s557710
Diabetes mellitus tipo 2 y su interrelación con la enfermedad de hígado graso no alcohólico
Marín-Tirado, H. A., & Torres Cueva, G. D. L. Á. (2024) · Repositorio Institucional (Universidad de Cuenca)
Ayuso, M. C. (2023) · e_Buah
A Comprehensive Guide to Non-alcoholic Fatty Liver Disease
Kang, J.-S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1001700
Miyazawa, Y., Wada, T., Iwasa, Y., Fuse, K., Shioneri, H., Onogi, Y., Sameshima, A., Yoshida, T., Takasaki, I., Mori, H., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102279
Tang, Y., Li, T., Kuang, X., Wu, J., Qin, D., Luo, M., Han, Z., & Zheng, Y. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.121009
Zhang, Y., Guo, Z., Wei, K., Li, R., Cao, J., Zhao, L., Wu, S., Feng, C., Jiang, Q., & Xue, Y. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109763
Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy
Kamar, N. M. R., el-Din, S. H. S., Michel, H. E., El-Lakkany, N. M., & Mokhtar, D. (2024) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2024.291298.1173
Abudureyimu, M., Shen, C., Sun, R., Sun, J., Wan, L., Wang, Q., & Chen, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-64760-w
Zhang, K., Long, N., Zhang, L., Zhang, J., Liu, Y., Chen, Z., Zheng, H., Mao, Y., Li, S., Du, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-68582-8
MANCINI, G. (2026) · Electronic Theses and Dissertations Repository (University of Pisa)
Kong, X., Chen, Y.-L., Li, R., Shang, L., & Sha, S. (2026) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70240
Yang, T., Chen, L., Luo, H., Wang, L., Jiang, X., Yang, H., Chen, L., Qian, S., Wang, T., Li, B., et al. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110532
Kovalevska, M., Ramanauskaite, G., Markevičiūtė, A., & Unikaitė, R. (2026) · Sveikatos mokslai · doi:10.35988/sm-hs.2026.176
BARIATRINIŲ OPERACIJŲ NAUDA KONTROLIUOJANT 2 TIPO CUKRINĮ DIABETĄ
Mazaliauskaitė, L., & Janulytė, G. (2026) · Sveikatos mokslai · doi:10.35988/sm-hs.2026.193
Taha, W. A., Alelyan, U. A. A., Hashim, R. D., Jawad, Z. N., Jameel, M. K., & Mustafa, M. A. (2024) · Journal of Animal Health and Production · doi:10.17582/journal.jahp/2024/12.s1.351.356
Komarytsia, O. Y., Korolyuk, O. Y., Radchenko, O. M., Borovets, M. O., & Strilchuk, L. M. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.8.2025.1654
Etuk, A. A., Eyam, L. E., Ekpe, L. E., Ene, A., Onuche, O. L., Babatope, O. A., Essien, S. I., Nkereuwem, U. E., & Ebiekpi, I. U. (2026) · European Journal of Medical and Health Research · doi:10.59324/ejmhr.2026.4(5).15
Chen, M., Tan, J., Huang, M., Zhan, T., Han, Z., Liu, M., Lu, Y., & Tian, X. (2026) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2026.25649
Lifestyle Evaluation of Insulin Resistant People
Neliubšienė, S. (2025) · Lithuanian University of Health Sciences
Miao, C., Chen, Y., Du, P., Liu, J., Sun, X., & Zhao, Y. (2024) · Endokrynologia Polska · doi:10.5603/ep.102028
КЛІНІЧНИЙ ПРОФІЛЬ ПАЦІЄНТІВ ІЗ НЕАЛКОГОЛЬНОЮ ЖИРОВОЮ ХВОРОБОЮ ПЕЧІНКИ ТА ІНСУЛІНОРЕЗИСТЕНТНІСТЮ
Козак, О. А. (2024) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2024.v.i3.14901
Desale, S. R., Patro, S., Das, S., Jindal, V., Karlapudi, S. S., Karanam, M., Naik, P. U., & Sahoo, J. P. (2026) · Cureus · doi:10.7759/cureus.109099
Cui, Y., Li, F., Li, T., Sun, W., 石海燕, & 成云云 (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1846441
Bewket, B., Kebede, A. M., Abawa, E. D., Belete, A. M., Anteneh, Z. A., & Pimenta, A. M. (2026) · Sage Open Chronic Disease · doi:10.1177/27558428261471362
Lapolla, A., & Dalfrà, M. G. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2587206
Wani, Z., Sharma, A. K., Muzamil, S., & Lone, Y. (2026) · Journal of Veterinary and Animal Sciences · doi:10.51966/jvas.2026.57.1.208-216
Cordero, V. K. R. (2023) · Revista estudiantil CEUS
Naidoo, K. (2025) · ResearchSpace (University of KwaZulu-Natal)
Tsikli, V. (2025) · eScholarship@McGill (McGill) · doi:10.82308/6659
Corso, M. P. X. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2025.tde-16092025-115649
Worry, Fear, or Attention? Is Generation Z Getting Metabolically Older Prematurely Due to Obesity?
Shah, S. S., Kanani, E. A. M., Kharat, S. K., Shah, P. S., & Shah, R. M. (2024) · Journal of Bariatric Surgery · doi:10.4103/jbs.jbs_16_24
Lago Sampedro, A. M. (2025) · Repositorio Institucional de la Universidad de Málaga (University of Málaga)
Li, G., Wang, C., & Yang, W. (2026) · Translational Pediatrics · doi:10.21037/tp-2026-0416
Rafiq, A., Baba, D., Jha, S., & Mushtaq, S. (2025) · Journal of Emerging Technologies and Innovative Research · doi:10.56975/jetir.v12i4.560568
Yan, H., Huang, C., Shen, X., Li, J., Zhou, S., & Li, W. (2022) · doi:10.3389/fendo.2022.923606.s001
Niu, C., Tu, Y., Jin, Q., Chen, Z., Yuan, K., Wang, M., Zhang, P., Luo, J., Li, H., Yang, Y., et al. (2023) · doi:10.3389/fcimb.2023.1157368.s002
Tian, S., Yu, M., Liu, J., & Peng, X. (2025) · Research Square · doi:10.21203/rs.3.rs-7988743/v1
Effects of Berberine on Insulin-Sensitive Tissues: Nutrient-Derived Modulator of Metabolic Disease
Harrison, M., Achilleos, N., & Tsiani, E. (2026) · Cells · doi:10.3390/cells15211984
Xie, J., Zhong, F., Guo, Z., Li, X., Wang, J., Gao, Z., Chang, B., & Yang, J. (2022) · doi:10.3389/fendo.2022.960835.s001
Gao, X., Chen, Y., Wang, X., Chen, Y., Chen, X., Li, H., & Ye, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1615851
Non-alcoholic fatty liver disease, metabolic dysfunction and sarcopenia
Shavkuta, G. V., Rostov-on- Don, R., Gavrilyukov, V. A., Kovalenko, V. N., Zubkova, A. S., & Nalgieva, Z. M. (2025) · Terapevt (General Physician) · doi:10.33920/med-12-2506-06
Uric Acid: Is It Time to Come in From the Cold?
Swislocki, A. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0037
Zhu, M., Pan, F., Jia, L., Wu, R., Zhao, Y., Zheng, W., & Zhang, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3214449/v1
Porupureddy, M. S., Mattaparthi, N. S. M., Velaga, L., Achanta, C. R., Chadaram, B., & Panthagada, H. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.101983
Rasheed, S., Shahid, A., Sarfraz, A., Tabassum, S., Mudassar, S., & Habib, B. (2025) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v6i1.2456
Fernandes, J. P. D. M., Ribeiro, R. B., NETO, J. A. P. L., Mendes, I. B., Queiroz, L. F. D., Filho, J. M. D. S., ROLIM, P. R. Q., & de Figueiredo, P. R. L. (2025) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.18n.3-166
The impact of liver disease and diet on skin condition
Gugała, M., Mulik-Buczma, J., & Serrafi, A. (2025) · Aesthetic Cosmetology and Medicine · doi:10.52336/acm.2025.010
Aujara, K. M., Ahmed, S., Muhammad, A. T., Abubakar, I., Abubakar, A. I., Mohammad, Y., & Abdulmalik, A. (2025) · BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE · doi:10.64290/bima.v9i2b.1279
The Relationship Between Bone Morphogenic Protein-4 and Visceral-Central Adiposity
Can, S. T., Tubaş, F., Gökçe, N., Kiraz, A., İpekten, F., Karaman, Z. F., Altay, D., Şıraz, Ü. G., Özkul, Y., & Göksülük, D. (2025) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2025.28.5.312
Hernández Gómez, G. D. (2025) · El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León)
Velaz Perelló, U., & Montoro Huguet, M. A. (2023) · Zaguan (University of Zaragoza Repository)
Santos, R. K. F. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Jhee, J. H., Bae, W., Kim, H. J., Lee, H. S., Kang, S., Lee, J. I., Park, H. C., & Choi, H. Y. (2026) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.25.246
Mehmood, A., Ahmad, I., & Mehmood, S. (2026) · Developmental medico-life-sciences · doi:10.69750/dmls.03.02.0187
Multivariate analysis of the effects of minerals and trace elements on insulin resistance
Güntürk, A., Eryılmaz, M., & Yılmaz, K. (2026) · European journal of medical research · doi:10.1186/s40001-026-04526-2
Zhang, L., Xu, R., Yu, C., Dai, L., & Zhang, Z. (2026) · The FASEB Journal · doi:10.1096/fj.202600215r
Dyomshina, O. O., Krynytska, H., & Zhyliuk, V. (2026) · Regulatory Mechanisms in Biosystems · doi:10.15421/0226095
Metadata
- Authors
- Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T.
- Affiliations
- The University of Tokyo (JP)
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- Toranomon Hospital (JP)
- Corresponding author
- Kubota, Naoto
- Kadowaki, Takashi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-16
- Volume
- 22
- Issue
- 8
- Pages
- 4156
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8072900
- OpenAlex
- W3155254720
- Cited by
- 448
- References
- 195
- Citations by year
- 2026: 72 · 2025: 129 · 2024: 125 · 2023: 80 · 2022: 37 · 2021: 5
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (19K17977)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, hepatic insulin resistance, hepatic steatosis, liver fibrosis, de novo lipogenesis, gut microbiota, metabolic syndrome, obesity, type 2 diabetes, endoplasmic reticulum stress, liver inflammation, hepatocarcinogenesis
- MeSH terms
- Animals, Humans, Insulin, Signal Transduction, Metabolic Syndrome, Lipogenesis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.